How to Buy Regulus Therapeutics Stock

Regulus Therapeutics Inc

Regulus Therapeutics Inc. , a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Regulus Therapeutics stock last closed at $7.98, up 136.8% from the previous day, and has increased 246.96% in one year. It has overperformed other stocks in the Biotechnology industry by 3.24 percentage points. Regulus Therapeutics stock is currently +861.45% from its 52-week low of $0.83, and -2.68% from its 52-week high of $8.20.

As of Apr 30, 2025, there are 66.24M shares of RGLS outstanding. The market capitalization of RGLS is $528.62M. In the past 24 hours, 28.5M RGLS shares were traded.

How to Buy Regulus Therapeutics Stock

Not sure how to invest in Regulus Therapeutics stock? Here's how.

  1. Decide where to buy Regulus Therapeutics stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you decide where to buy Regulus Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit money your brokerage account: Select your payment method and add your details.
  4. Research Regulus Therapeutics stock: The Regulus Therapeutics ticker symbol is RGLS. Is Regulus Therapeutics stock a good investment? Should you buy shares of RGLS? How do RGLS's underlying business fundamentals look? Do top analysts think Regulus Therapeutics is a good buy? Why has RGLS's stock price moved recently? (Hint: Our stock market research website can help you evaluate if RGLS is a good stock to buy).
  5. Place your RGLS purchase: Decide if you will purchase RGLS shares at the current market price or use a limit order to buy RGLS stock at a specific price.
  6. Keep tabs on your investment in RGLS: Create a watchlist to get the latest news on your new investment in Regulus Therapeutics shares.

Step 1: Decide where to buy Regulus Therapeutics stock

You will need an online brokerage account to access the NASDAQ market and buy RGLS stock.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world financial markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've picked the best brokerage, the next step is to fill out some personal info so you can invest in RGLS today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to open a new brokerage account.
  1. Submit your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you have filled out your info on one of the best stock market apps, you need to deposit funds:

Watch the walkthrough below if you need help transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Regulus Therapeutics stock

Once you have decided on the best place to buy Regulus Therapeutics stock, it's absolutely critical to analyze their stock prior to buying, so you can understand the risk and opportunity.

Regulus Therapeutics Metrics

RGLS Price
$7.98
1w %
212.94%
1y %
246.96%
5y %
56.47%
P/E
-9.73x
P/B
6.92x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$46.36M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$528.62M
Next Earnings
May 7, 2025
Next Dividend
N/A

RGLS Overview

WallStreetZen was built to help part-time investors do more accurate fundamental analysis in less time.

You can see all of the due diligence checks on RGLS's stock page.

Is RGLS stock undervalued or overvalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge RGLS's true value.

Using relative valuations measures:

  • RGLS could be overvalued based on its P/B ratio of 6.92x, relative to Biotechnology industry P/B ratio of 4.45x

You can do more valuation analysis on RGLS's stock here.

RGLS Financial Health

Passed Financial Due Diligence Checks:

  • RGLS has cash burn of 42013000. It has enough cash and short-term investments to cover this for at least one year.
  • RGLS has $75.84M in cash and short term investments. This is enough to cover its annual cash burn of $42.01M.
  • Total RGLS debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than long-term liabilities on the RGLS balance sheet.
  • RGLS has a low debt to equity ratio of 0.1.
  • There are more short-term assets than short-term liabilities on the RGLS balance sheet.

Do analysts think it's a good time to buy Regulus Therapeutics stock

Out of 5 sell side analysts who give recommendations on RGLS, the consensus analyst rating on Regulus Therapeutics is a Buy

Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dive deeper into what analysts are projecting on the Regulus Therapeutics stock forecast page.

Metrics for Advanced RGLS Traders

SMA10
3.13
SMA20
2.45
SMA50
1.81
SMA100
1.6
SMA200
1.59
MACD
0.82
MACD Signal
0.38
MACD Histogram
0.44
RSI
94.63
Stochastic %K
89.77
Stochastic %D
89.28
StochRSI %K
94.19
StochRSI %D
94.4

Are RGLS executives and large shareholders buying or selling the stock?

In the last 12 months, insiders at RGLS have bought more shares than they have sold.

David Baltimore, Director of RGLS, was the latest RGLS insider to buy. They bought $20,786.60 worth of RGLS shares on Jan 30, 2025.

Dig into more about who owns RGLS shares here.

Does RGLS stock generate passive income?

No, Regulus Therapeutics doesn't provide an income stream by paying out dividends.

What do other traders have to say about RGLS?

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Place your RGLS purchase

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are generally the best for newer investors.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at an exact price limit, use a limit order.

Press the Open button and eToro will execute the order.

If you require additional help with buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your investment in RGLS

Now that you own some shares in RGLS, you'll want to keep up with your company.

Put RGLS on a watchlist to track the most important metrics related to your RGLS stock.

RGLS Feed

How to Buy Stock in Regulus Therapeutics

To reiterate, here are the 6 steps for buying Regulus Therapeutics stock:

  1. Decide where to buy Regulus Therapeutics stock
  2. Create a brokerage account
  3. Deposit money your brokerage account
  4. Research Regulus Therapeutics stock
  5. Place your RGLS purchase
  6. Keep tabs on your investment in RGLS

If you require a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to monitor your new investment in Regulus Therapeutics, hit the button below to create your watchlist.

NASDAQ: RGLS
$7.98+4.61 (+136.8%)
Updated Apr 30, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: RGLS
$7.98+4.61 (+136.8%)
Updated Apr 30, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Regulus Therapeutics share?

As of Apr 30, 2025, it costs $7.98 to buy one share of Regulus Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.376 shares of RGLS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Regulus Therapeutics stock?

According to 5 Wall Street analysts who monitor Regulus Therapeutics, their consensus recommendation is to buy Regulus Therapeutics stock.

What is the best way to buy Regulus Therapeutics stock?

One way to place an order for Regulus Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.